UV laser blasts through scar tissue to unclog arteries
Patients at University College London Hospital NHS Foundation Trust are the first in the country to benefit from the latest Excimer laser technology which unclogs arteries in a matter of minutes.

Developed by Colorado Springs, Colorado-based Spectranetics Corporation, the Excimer laser blasts obstructing tissue into microscopic particles that are then absorbed into the bloodstream - restoring natural blood flow and bringing relief from pain, without the need for complex bypass surgery.
The ultra-violet light is transmitted through flexible glass fibres that are guided into place by a catheter which is advanced through the blockage.
The treatment is highly effective for patients who have developed total blockage of arteries following previous angioplasty or stent placement (a minimally invasive technique to widen narrowed arteries.)
An increase in lining tissue of the damaged artery can occur following the procedure in up to 30 per cent of cases and the Excimer laser technique helps to improve the long-term results and avoid bypass surgery.
Dr Joe Brookes, vascular radiologist and divisional clinical director for imaging and vascular services, said: ’If patients develop a scarring reaction following angioplasty or stent placement, unwanted tissue can begin to build up on the artery wall which constricts them again. Obviously this puts the patient at further risk.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Comment: The UK is closer to deindustrialisation than reindustrialisation
"..have been years in the making" and are embedded in the actors - thus making it difficult for UK industry to move on and develop and apply...